A phase II study of rituximab combined with pirarubicincyclophosphamide, vincristine and prednisolone regimen as first-line therapy for patients with indolent B-cell lymphoma

Hisashi Tsurumi, Takeshi Hara, Naoe Goto, Jun Ichi Kitagawa, Nobuhiro Kanemura, Takeshi Yoshikawa, Senji Kasahara, Hideko Goto, Kenji Fukuno, Toshiki Yamada, Michio Sawada, Masahito Shimizu, Takeshi Takahashi, Tsuyoshi Takami, Hisataka Moriwaki

研究成果: Article査読

3 被引用数 (Scopus)

フィンガープリント

「A phase II study of rituximab combined with pirarubicincyclophosphamide, vincristine and prednisolone regimen as first-line therapy for patients with indolent B-cell lymphoma」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

Medicine & Life Sciences